Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1AQ1

HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE

Experimental procedure
Source typeSYNCHROTRON
Source detailsELETTRA BEAMLINE 5.2R
Synchrotron siteELETTRA
Beamline5.2R
Temperature [K]100
Detector technologyIMAGE PLATE AREA DETECTOR
Collection date1996-12
DetectorMARRESEARCH
Spacegroup nameP 21 21 21
Unit cell lengths53.500, 70.500, 73.600
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution25.000 - 2.000
Rwork0.220
R-free0.26000
Structure solution methodDIFFERENCE FOURIER
Starting model (for MR)1hck
Data reduction softwareMOSFLM
Data scaling softwareCCP4 ((SCALA))
Phasing softwareCCP4
Refinement softwareREFMAC
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]20.0002.100
High resolution limit [Å]2.0002.000
Rmerge0.101

*

0.500
Total number of observations53349

*

Number of reflections17731
<I/σ(I)>5.71.4
Completeness [%]92.989.4
Redundancy32.7
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1Vapor diffusion, sitting drop

*

7.420

*

PROTEIN AT 10MG/ML IN 15MM NACL, 10MM HEPES, PH7.4, MIXED WITH WELL BUFFER (50MM AMMONIUM ACETATE, 10% PEG4K, 0.1M HEPES PH 7.4) IN EQUAL VOLUMES, THEN VAPOUR DIFFUSION AGAINST WELL BUFFER. CDK2 CRYSTALS WERE SOAKED FOR 20 HOURS IN A SOLUTION OF 0.5MM STAUROSPORINE IN 1X WELL BUFFER PREPARED FROM STOCKS 2X WELLBUFFER AND 10MM STAUROSPORINE IN 100% DMSO., vapor diffusion
Crystallization Reagents in Literatures
IDcrystal IDsolutionreagent nameconcentration (unit)details
11dropCDK210 (mg/ml)
21drop15 (mM)
31dropHEPES10 (mM)
41reservoir50 (mM)
51reservoirPEG400010 (%)
61reservoirHEPES0.1 (M)

218500

數據於2024-04-17公開中

PDB statisticsPDBj update infoContact PDBjnumon